H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Census population 383,997. Louisiana Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New Orleans clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New Orleans storefront.
Platelet Rich Plasma (PRP) Therapy in New Orleans, LA for clinics & physicians. PRP therapy systems with 1… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Obesity 34%; arthritis 25.3%. Those three PLACES crude rates (plus Census 383,997) are the local facts on this page. Everything else is the national platelet rich plasma therapy catalog and JH paperwork.
National Platelet Rich Plasma (PRP) Therapy notes (how the product actually works)Three grains, kept separate on purpose. City: Census 383,997 and CDC PLACES crude rates. State: Louisiana Department of Health, Diabetes Belt counties present. Federal: 21 CFR 1271 and Novitas Solutions LCDs. CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure.
Practices hire us when the fridge is full and the chart is a mess. CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. That is a planning input. The work is still receiving, indication language, and not mixing PRP with CTP codes. That is the platelet rich plasma therapy account.
CDC PLACES (2023, crude prevalence) estimates 15.1% of adults — 3.1 points above the U.S. 12% figure. Obesity is 34%; arthritis is 25.3%. That is place-level BRFSS modeling, not a clinic census and not a New Orleans trial.
A 510(k)-cleared device has a different regulatory file than a 361 HCT/P. Do not store, bill, or describe them as the same SKU family. Your SOP should split receiving and indication language.
No. Novitas Solutions writes coverage. We train staff on documentation patterns those articles already require (wound measurements, conservative care, units). That is support, not a coverage guarantee.
We distribute nationwide. Transit time depends on carrier and SKU, not on a fictional local warehouse. Ask for current lead times on the specific centrifuge, allograft, or CTP you intend to bill.
Bring specialty, monthly joint / regenerative volume, and whether you bill JH FFS, Advantage, workers’ comp, or cash-pay. We already have PLACES 15.1% diabetes and 25.3% arthritis for New Orleans — tell us how that matches your panel. Book 15 minutes with Joe or use the contact form.
Contact us to learn how Hawk Medical supports practices in New Orleans, LA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New Orleans is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New Orleans — 3.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Louisiana Part B wound biologics follow this contractor (siblings: AR, CO, MS, NM, OK, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New Orleans. Useful for joint-program math; still needs a diagnosis and privileging.
No New Orleans storefront. Joe Bradley is an active practice owner. platelet rich plasma therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.